The multiverse nature of epithelial to mesenchymal transition.

[1]  Margaret P. Chapman,et al.  Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer , 2018, Nature Communications.

[2]  Xi-lin Du,et al.  LncRNA HOTAIR contributes to the malignancy of hepatocellular carcinoma by enhancing epithelial-mesenchymal transition via sponging miR-23b-3p from ZEB1. , 2018, Gene.

[3]  M. Hsiao,et al.  A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer , 2018, Oncogene.

[4]  Angela N. Brooks,et al.  An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer , 2018, eLife.

[5]  Stefan Enroth,et al.  Genome–wide binding of transcription factor ZEB1 in triple‐negative breast cancer cells , 2018, Journal of cellular physiology.

[6]  T. Voet,et al.  Identification of the tumour transition states occurring during EMT , 2018, Nature.

[7]  Lu Wen,et al.  Single-cell RNA-seq analysis unveils a prevalent epithelial/mesenchymal hybrid state during mouse organogenesis , 2018, Genome Biology.

[8]  N. Wu,et al.  Interplay between long noncoding RNA ZEB1-AS1 and miR-101/ZEB1 axis regulates proliferation and migration of colorectal cancer cells. , 2018, American journal of translational research.

[9]  Junnian Zheng,et al.  PTBP3-Mediated Regulation of ZEB1 mRNA Stability Promotes Epithelial-Mesenchymal Transition in Breast Cancer. , 2018, Cancer research.

[10]  Robert A. Weinberg,et al.  EMT in cancer , 2018, Nature Reviews Cancer.

[11]  G. Berx,et al.  Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity. , 2017, Trends in genetics : TIG.

[12]  Chi-Tan Hu,et al.  Snail collaborates with EGR-1 and SP-1 to directly activate transcription of MMP 9 and ZEB1 , 2017, Scientific Reports.

[13]  Daniele Vergara,et al.  The Many-Faced Program of Epithelial–Mesenchymal Transition: A System Biology-Based View , 2017, Front. Oncol..

[14]  Shawn M. Gillespie,et al.  Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer , 2017, Cell.

[15]  E. Pilozzi,et al.  Alternative polyadenylation of ZEB1 promotes its translation during genotoxic stress in pancreatic cancer cells , 2017, Cell Death & Disease.

[16]  G. Christofori,et al.  miR-1199-5p and Zeb1 function in a double-negative feedback loop potentially coordinating EMT and tumour metastasis , 2017, Nature Communications.

[17]  K. Hu,et al.  Deep sequencing reveals a global reprogramming of lncRNA transcriptome during EMT. , 2017, Biochimica et biophysica acta. Molecular cell research.

[18]  Li Ma,et al.  USP51 promotes deubiquitination and stabilization of ZEB1. , 2017, American journal of cancer research.

[19]  Ling Li,et al.  Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer , 2017, Molecular Cancer.

[20]  Peng Huang,et al.  Long noncoding RNA XIST expedites metastasis and modulates epithelial–mesenchymal transition in colorectal cancer , 2017, Cell Death & Disease.

[21]  I. Fournier,et al.  β-Catenin Knockdown Affects Mitochondrial Biogenesis and Lipid Metabolism in Breast Cancer Cells , 2017, Front. Physiol..

[22]  J. Couso,et al.  Classification and function of small open reading frames , 2017, Nature Reviews Molecular Cell Biology.

[23]  Zhiguo Lin,et al.  PARK2 negatively regulates the metastasis and epithelial-mesenchymal transition of glioblastoma cells via ZEB1 , 2017, Oncology letters.

[24]  Shanshan Liu,et al.  A long non-coding RNA lncRNA-PE promotes invasion and epithelial–mesenchymal transition in hepatocellular carcinoma through the miR-200a/b-ZEB1 pathway , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[25]  C. Pilarsky,et al.  The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer , 2017, Nature Cell Biology.

[26]  F. Bertucci,et al.  A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability , 2017, Nature Medicine.

[27]  E. Maher,et al.  Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma. , 2017, Cell reports.

[28]  M. C. Llorens,et al.  Phosphorylation Regulates Functions of ZEB1 Transcription Factor , 2016, Journal of cellular physiology.

[29]  Z. Zong,et al.  Induction of epithelial-mesenchymal transition (EMT) by Beclin 1 knockdown via posttranscriptional upregulation of ZEB1 in thyroid cancer cells , 2016, Oncotarget.

[30]  Luc Girard,et al.  ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. , 2016, The Journal of clinical investigation.

[31]  A. Dragoi,et al.  FLASH protects ZEB1 from degradation and supports cancer cells' epithelial-to-mesenchymal transition , 2016, Oncogenesis.

[32]  Zhifu Sun,et al.  A genetic cell context-dependent role for ZEB1 in lung cancer , 2016, Nature Communications.

[33]  Jingliang Cheng,et al.  Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis , 2016, Scientific Reports.

[34]  H. Piwnica-Worms,et al.  Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth , 2016, Oncogene.

[35]  Z. Yao,et al.  LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway , 2016, Oncotarget.

[36]  Zhiyong Wu,et al.  Long non-coding RNA regulation of epithelial–mesenchymal transition in cancer metastasis , 2016, Cell Death and Disease.

[37]  M. Roussel,et al.  Zeb1 controls neuron differentiation and germinal zone exit by a mesenchymal-epithelial-like transition , 2016, eLife.

[38]  Yi Xing,et al.  Determination of a Comprehensive Alternative Splicing Regulatory Network and Combinatorial Regulation by Key Factors during the Epithelial-to-Mesenchymal Transition , 2016, Molecular and Cellular Biology.

[39]  M. T. Pinto,et al.  Proteomic Analysis of Epithelial to Mesenchymal Transition (EMT) Reveals Cross-talk between SNAIL and HDAC1 Proteins in Breast Cancer Cells* , 2016, Molecular & Cellular Proteomics.

[40]  Ming Tan,et al.  GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification , 2016, Scientific Reports.

[41]  C. Meisinger,et al.  ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types , 2016, Nature Communications.

[42]  G. Stein,et al.  Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes , 2016, Oncotarget.

[43]  Reka Albert,et al.  Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular phenotypes , 2015, npj Systems Biology and Applications.

[44]  V. LeBleu,et al.  EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer , 2015, Nature.

[45]  Catherine Ha Ta,et al.  An Ovol2-Zeb1 Mutual Inhibitory Circuit Governs Bidirectional and Multi-step Transition between Epithelial and Mesenchymal States , 2015, PLoS Comput. Biol..

[46]  J. Xie,et al.  BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells. , 2015, Cancer letters.

[47]  R. Weinberg,et al.  Distinct EMT programs control normal mammary stem cells and tumour-initiating cells , 2015, Nature.

[48]  Meiyan Wu,et al.  HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer , 2015, PloS one.

[49]  A. del Sol,et al.  Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival , 2015, PloS one.

[50]  Xudong Dai,et al.  Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival. , 2015, Cancer research.

[51]  Eshel Ben-Jacob,et al.  OVOL guides the epithelial-hybrid-mesenchymal transition , 2015, Oncotarget.

[52]  D. Bowtell,et al.  The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer , 2014, Oncotarget.

[53]  D. Dean,et al.  Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis , 2014, Nature Communications.

[54]  Qin Chen,et al.  Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors , 2014, Oncotarget.

[55]  A. Aboussekhra,et al.  MicroRNA-141 and MicroRNA-146b-5p Inhibit the Prometastatic Mesenchymal Characteristics through the RNA-binding Protein AUF1 Targeting the Transcription Factor ZEB1 and the Protein Kinase AKT* , 2014, The Journal of Biological Chemistry.

[56]  T. Tan,et al.  Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients , 2014, EMBO molecular medicine.

[57]  Petra C. Schwalie,et al.  Identification of the transcription factor ZEB1 as a central component of the adipogenic gene regulatory network , 2014, eLife.

[58]  V. Díaz,et al.  Regulation of the protein stability of EMT transcription factors , 2014, Cell adhesion & migration.

[59]  W. Woodward,et al.  ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1 , 2014, Nature Cell Biology.

[60]  Shuhan Sun,et al.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.

[61]  Bogi Andersen,et al.  Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressor. , 2014, Developmental cell.

[62]  Qing Nie,et al.  Transcriptional mechanisms link epithelial plasticity to adhesion and differentiation of epidermal progenitor cells. , 2014, Developmental cell.

[63]  Dong Wang,et al.  Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts , 2013, Stem cell reports.

[64]  M Choolani,et al.  An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530) , 2013, Cell Death and Disease.

[65]  Eshel Ben-Jacob,et al.  MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination , 2013, Proceedings of the National Academy of Sciences.

[66]  H. Ford,et al.  Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2. , 2013, Cancer research.

[67]  Richard C. McEachin,et al.  Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer , 2013, PloS one.

[68]  François-Michel Boisvert,et al.  Direct Detection of Alternative Open Reading Frames Translation Products in Human Significantly Expands the Proteome , 2013, PloS one.

[69]  Ugo Ala,et al.  MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling , 2013, Cell.

[70]  Jianhua Xing,et al.  Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition. , 2013, Biophysical journal.

[71]  Robert A. Weinberg,et al.  Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity , 2013, Cell.

[72]  Udo Schumacher,et al.  Dual Roles of the Transcription Factor Grainyhead-like 2 (GRHL2) in Breast Cancer* , 2013, The Journal of Biological Chemistry.

[73]  G. Giannelli,et al.  Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature. , 2013, Molecular bioSystems.

[74]  J. Foekens,et al.  miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs , 2013, Breast Cancer Research.

[75]  D. Dean,et al.  Sequential Inductions of the ZEB1 Transcription Factor Caused by Mutation of Rb and Then Ras Proteins Are Required for Tumor Initiation and Progression* , 2013, The Journal of Biological Chemistry.

[76]  Jeffrey T. Chang,et al.  FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. , 2013, Cancer research.

[77]  G. Berx,et al.  Regulatory networks defining EMT during cancer initiation and progression , 2013, Nature Reviews Cancer.

[78]  A. Postigo,et al.  ZEB1 Imposes a Temporary Stage-Dependent Inhibition of Muscle Gene Expression and Differentiation via CtBP-Mediated Transcriptional Repression , 2013, Molecular and Cellular Biology.

[79]  D. Dean,et al.  EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness , 2012, Cellular and Molecular Life Sciences.

[80]  Li Ma,et al.  MicroRNA control of epithelial–mesenchymal transition and metastasis , 2012, Cancer and Metastasis Reviews.

[81]  Benoît Vanderperre,et al.  HAltORF: a database of predicted out-of-frame alternative open reading frames in human , 2012, Database J. Biol. Databases Curation.

[82]  B. Cieply,et al.  Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2. , 2012, Cancer research.

[83]  Maximilian Reichert,et al.  EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.

[84]  Yun Cui,et al.  Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition* , 2011, The Journal of Biological Chemistry.

[85]  A. Postigo,et al.  β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness , 2011, Proceedings of the National Academy of Sciences.

[86]  Helmut Schaider,et al.  Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma. , 2011, The Journal of investigative dermatology.

[87]  Nicholas C. Flytzanis,et al.  An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype , 2011, PLoS genetics.

[88]  E. Lander,et al.  Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells , 2011, Cell.

[89]  A. G. de Herreros,et al.  Functional Cooperation between Snail1 and Twist in the Regulation of ZEB1 Expression during Epithelial to Mesenchymal Transition* , 2011, The Journal of Biological Chemistry.

[90]  Stuart Thomson,et al.  A systems view of epithelial–mesenchymal transition signaling states , 2010, Clinical & Experimental Metastasis.

[91]  Kakajan Komurov,et al.  Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes , 2010, Proceedings of the National Academy of Sciences.

[92]  Julia Schüler,et al.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.

[93]  G. Berx,et al.  The role of the ZEB family of transcription factors in development and disease , 2009, Cellular and Molecular Life Sciences.

[94]  Sun-Mi Park,et al.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.

[95]  D. Dean,et al.  The zinc finger transcription factor ZFHX1A is linked to cell proliferation by Rb-E2F1. , 2007, The Biochemical journal.

[96]  S. Badve,et al.  NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2 , 2007, Oncogene.

[97]  D. Darling,et al.  Cell-specific phosphorylation of Zfhep transcription factor. , 2002, Biochemical and biophysical research communications.

[98]  J. Zavadil,et al.  Genetic programs of epithelial cell plasticity directed by transforming growth factor-β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[99]  D. Dean,et al.  Independent Repressor Domains in ZEB Regulate Muscle and T-Cell Differentiation , 1999, Molecular and Cellular Biology.

[100]  A. Puisieux,et al.  Pleiotropic Roles for ZEB1 in Cancer. , 2018, Cancer research.